Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium.
Schuurmans IK, Mulder RH, Baltramonaityte V, Lahtinen A, Qiuyu F, Rothmann LM, Staginnus M, Tuulari J, Burt SA, Buss C, Craig JM, Donald KA, Felix JF, Freeman TP, Grassi-Oliveira R, Huels A, Hyde LW, Jones SA, Karlsson H, Karlsson L, Koen N, Lawn W, Mitchell C, Monk CS, Mooney MA, Muetzel R, Nigg JT, Belangero SIN, Notterman D, O'Connor T, O'Donnell KJ, Pan PM, Paunio T, Ryabinin P, Saffery R, Salum GA, Seal M, Silk TJ, Stein DJ, Zar H, Walton E, Cecil CAM. Schuurmans IK, et al. Among authors: freeman tp. medRxiv [Preprint]. 2024 Jun 25:2024.06.23.24309353. doi: 10.1101/2024.06.23.24309353. medRxiv. 2024. PMID: 38978656 Free PMC article. Preprint.
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques.
Bond BW, Duric B, Spinazzola E, Trotta G, Chesney E, Li Z, Quattrone D, Tripoli G, Gayer-Anderson C, Rodriguez V, Ferraro L, La Cascia C, Tarricone I, Szöke A, Arango C, Bobes J, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Rutten BPF, de Haan L, Stilo S, Schürhoff F, Pignon B, Freeman TP, Vassos E, Murray RM, Austin-Zimmerman I, Di Forti M. Bond BW, et al. Among authors: freeman tp. Can J Psychiatry. 2025 Jan 15:7067437241290187. doi: 10.1177/07067437241290187. Online ahead of print. Can J Psychiatry. 2025. PMID: 39810593 Free PMC article.
A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders.
Di Forti M, Bond BW, Spinazzola E, Trotta G, Lynn J, Malkin R, Kamran Siddiqui N, Demir S, Opadokun T, Leung PBM, Li Z, Quattrone A, Baxter G, Appiah-Kusi E, Freeman TP, Walsh H, Squeri T, Semikina D, Amberson-Jones F, Austin-Zimmerman I, Meynen T, Quattrone D, Murray RM. Di Forti M, et al. Among authors: freeman tp. BJPsych Open. 2024 Dec 12;11(1):e1. doi: 10.1192/bjo.2024.782. BJPsych Open. 2024. PMID: 39663754 Free PMC article.
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.
Austin-Zimmerman I, Spinazzola E, Quattrone D, Wu-Choi B, Trotta G, Li Z, Johnson E, Richards AL, Freeman TP, Tripoli G, Gayer-Anderson C, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, Tosato S, Tarricone I, Berardi D, Bonora E, Seri M, D'Andrea G, Szöke A, Arango C, Bobes J, Sanjuán J, Santos JL, Arrojo M, Velthorst E, Bernardo M, Del-Ben CM, Rossi Menezes P, Selten JP, Jones PB, Kirkbride JB, Rutten BPF, Tortelli A, Llorca PM, de Haan L, Stilo S, La Barbera D, Lasalvia A, Schurnhoff F, Pignon B, van Os J, Lynskey M, Morgan C; EU-GEI WP2 Group; O' Donovan M, Lewis CM, Sham PC, Murray RM, Vassos E, Di Forti M. Austin-Zimmerman I, et al. Among authors: freeman tp. Psychol Med. 2024 Dec 6;54(15):1-13. doi: 10.1017/S0033291724002058. Online ahead of print. Psychol Med. 2024. PMID: 39637925 Free PMC article.
Methylomic signature of current cannabis use in two first-episode psychosis cohorts.
Dempster EL, Wong CCY, Burrage J, Hannon E, Quattrone D, Trotta G, Rodriguez V, Alameda L, Spinazzola E, Tripoli G, Austin-Zimmerman I, Li Z, Gayer-Anderson C, Freeman TP, Johnson EC, Jongsma HE, Stilo S, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, D'Andrea G, Galatolo M, Tortelli A, Pompili M, Selten JP, de Haan L, Menezes PR, Del Ben CM, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Jones PB, Breen G, Mondelli V, Dazzan P, Iyegbe C, Vassos E, Morgan C, Mukherjee D, van Os J, Rutten B, O'Donovan MC, Sham P, Mill J, Murray R, Di Forti M. Dempster EL, et al. Among authors: freeman tp. Mol Psychiatry. 2024 Oct 16. doi: 10.1038/s41380-024-02689-0. Online ahead of print. Mol Psychiatry. 2024. PMID: 39406996
195 results